25 May 2026
Apollo Hospitals guided Apollo HealthTech demerger and listing by Q4 FY27, targeting annualized revenue of ₹25,000 crore at listing.
Shareholders receive 195.2 HealthTech shares per 100 Apollo shares.
Every Finvezto stock note on Apollo Hospitals, dated and newest first. Coverage spans healthcare.
Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630. Stock notes are market commentary for general information and education. They are not investment advice, not a recommendation to buy or sell, and do not account for any individual's financial situation. Investment in securities is subject to market risks. Please read all related documents carefully before investing. Past performance is not a guarantee of future results.